The EUROPA study: Cardiovascular protection of perindopril among patients with stable coronary heart disease;L'étude EUROPA: Protection cardio-vasculaire avec le perindopril chez les patients avec coronaropathie stable

Revue Medicale de Liege

Volumn 58, Issue 11, 2003, Pages 713-716

  Scheen, A J ^a   Legrand, V ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Angiotensin concerting enzyme inhibitor; Cardiovascular disease; Coronary heart disease; Perindopril; Randomised controlled trial

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; PLACEBO;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART ARREST; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RISK REDUCTION; TREATMENT OUTCOME; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERINDOPRIL; PLACEBOS; RISK FACTORS; TREATMENT OUTCOME;

EID: 1642430943     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Scheen AJ, Lefèbvre PJ, Kulbertus H.- Comment je préviens ... les maladies cardio-vasculaires par une approche pharmacologique combinée: y a-t-il place pour une "Polypill"? Rev Med Liège, 2003, 58, 527-533.
2. EUROASPIRE II Study Group.- Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J, 2001, 22, 554-572.
3. Flather MD, Yusuf S, Kober L, et al.- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic review of data from individuals patients. Lancet, 2000, 355, 1575-1581.
4. The EUropean trial on Reduction Of cardiac events with Perindopril in patients with stable coronary Artery disease Investigators.- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet, 2003, 362, 782-788.
5. Remme WJ.- Reconsidering the management of all coronary artery disease patients: importance of the EUROPA trial. Eur Heart J, 2003, 5 (Suppl E), E23-E30.
6. Blood Pressure Lowering Treatment Trialist's Collaboration.-Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet, 2000, 355, 1955-1964.
7. PROGRESS Collaborative Group.- Randomised trial of a perindopril-based blood-pressure-lowering regime among 6,105 individuals with previous stroke or transient ischemic attack. Lancet, 2001, 358, 1033-1041.
8. Yusuf S, Sleight P, Pogue J, et al.- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med, 2000, 342, 145-53.
9. Scheen AJ.- L'étude HOPE, un essai clinique bicéphale aux résultats contrastés. Rev Med Liège, 2000, 55, 64-66.
10. Gomma AH, Fox KM, on behalf of the EUROPA Investigators.- The EUROPA trial: design, baseline demography and status of the substudies. Cardiovasc Drugs Ther, 2001, 15, 169-179.
11. Hurst M, Jarvis B.- Perindopril: an updated review of its use in hypertension. Drugs, 2001, 61, 867-896.
12. Simpson D, Noble S, Goa KL.- Perindopril in congestive heart failure. Drugs, 2002, 62, 1367-1377.
13. Rolland PH, Charpiot P, Friggi A, et al.- Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini pigs. Am J Cardiol, 1993, 71, 22E-27E.
14. Bartels LG, van den Hevrel ADFM, van Veldhuisen DJ, et al.- Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function. Am J Cardiol, 1999, 83, 332-336.
15. Bots ML, Remme WJ, Luscher TF, et al for the EUROPA-PERFECT Investigators.- PERindopril-Function of the Endothelium in Coronary Artery Disease Trial: the PERFECT study - sub study of EUROPA: rationale and design. Cardiovasc Drugs Ther, 2002, 16, 227-236.